Follow-up studies were done on 231 hemodialysis patients during a period of from one to 48 months to determine the natural history of hepatitis B surface antigenemia (HBs Ag). Of those studied, 113 (49%) exhibited HBs Ag. The probability of remaining HBs Ag positive over the mean follow-up period of 14.4 months was 62%. All of the 38 patients whose HBs Ag reverted to negative did so within ten months. Those patients whose HBs Ag reverted to negative had SGOT levels that were less frequently elevated than the patients with persistent antigenemia. Of hemodialysis patients with HBs Ag, 60% showed e antigen (HBe Ag).
(Arch Intern Med 139:178-180, 1979)
Ribot S, Rothstein M, Goldblat M, Grasso M. Duration of Hepatitis B Surface Antigenemia (HBs Ag) in Hemodialysis Patients. Arch Intern Med. 1979;139(2):178–180. doi:10.1001/archinte.1979.03630390036015
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: